Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain

Polo-like kinase 1 (Plk1) is a promising target for cancer therapy due to its essential role in cell division. In addition to a highly conserved kinase domain, Plk1 also contains a Polo-Box domain (PBD), which is essential for Plk1's subcellular localization and mitotic functions. We adopted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunyu, Zhang, Jing, Li, Dongsheng, Jiang, Jiandong, Wang, Yanchang, Si, Shuyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352051/
https://www.ncbi.nlm.nih.gov/pubmed/27902479
http://dx.doi.org/10.18632/oncotarget.13603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352051/
https://www.ncbi.nlm.nih.gov/pubmed/27902479
http://dx.doi.org/10.18632/oncotarget.13603

Ejemplares similares